Potent and Orally Active Small-Molecule Inhibitors of the MDM2-p53 Interaction

被引:161
作者
Yu, Shanghai [1 ,2 ,3 ,4 ]
Qin, Dongguang [1 ,2 ,3 ,4 ]
Shangary, Sanjeev [1 ,2 ,3 ,4 ]
Chen, Jianyong [1 ,2 ,3 ,4 ]
Wang, Guoping [1 ,2 ,3 ,4 ]
Ding, Ke [1 ,2 ,3 ,4 ]
McEachern, Donna [1 ,2 ,3 ,4 ]
Qiu, Su [1 ,2 ,3 ,4 ]
Nikolovska-Coleska, Zaneta [1 ,2 ,3 ,4 ]
Miller, Rebecca [1 ,2 ,3 ,4 ]
Kang, Sanmao [5 ]
Yang, Dajun [5 ]
Wang, Shaomeng [1 ,2 ,3 ,4 ]
机构
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA
[5] Ascenta Therapeut Inc, Malvern, PA 19355 USA
基金
美国国家卫生研究院;
关键词
PROTEIN-PROTEIN INTERACTION; STRUCTURE-BASED DESIGN; CANCER-THERAPY; P53-MDM2; INTERACTION; P53; ANTAGONISTS; ACTIVATION; DISCOVERY; CELLS; GROWTH;
D O I
10.1021/jm901400z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report herein the design of potent and orally active small-molecule inhibitors of the MDM2-p53 interaction, Compound 5 binds to MDM2 with a K-i of 0.6 nM, activates p53 at concentrations its low as 40 nM, and potently and selectively inhibits cell growth in tumor cells with wild-type p53 over tumor cells with mutated/deleted p53. Compound 5 has a good oral bioavailability and effectively inhibits tumor growth in the SJSA-1 xenograft model.
引用
收藏
页码:7970 / 7973
页数:4
相关论文
共 22 条
[1]   Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models [J].
Bowman, Anna L. ;
Nikolovska-Coleska, Zaneta ;
Zhong, Haizhen ;
Wang, Shaomeng ;
Carlson, Heather A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (42) :12809-12814
[2]   Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy [J].
Chène, P .
NATURE REVIEWS CANCER, 2003, 3 (02) :102-109
[3]   Structure-based design of potent non-peptide MDM2 inhibitors [J].
Ding, K ;
Lu, Y ;
Nikolovska-Coleska, Z ;
Qiu, S ;
Ding, YS ;
Gao, W ;
Stuckey, J ;
Krajewski, K ;
Roller, PP ;
Tomita, Y ;
Parrish, DA ;
Deschamps, JR ;
Wang, SM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (29) :10130-10131
[4]   Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction [J].
Ding, Ke ;
Lu, Yipin ;
Nikolovska-Coleska, Zaneta ;
Wang, Guoping ;
Qiu, Su ;
Shangary, Sanjeev ;
Gao, Wei ;
Qin, Dongguang ;
Stuckey, Jeanne ;
Krajewski, Krzysztof ;
Roller, Peter P. ;
Wang, Shaomeng .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) :3432-3435
[5]   A nonpeptidic sulfonamide inhibits the p53-mdm2 interaction and activates p53-dependent transcription in mdm2-overexpressing cells [J].
Galatin, PS ;
Abraham, DJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) :4163-4165
[6]   Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53 [J].
García-Echeverría, C ;
Chène, P ;
Blommers, MJJ ;
Furet, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (17) :3205-3208
[7]   Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells [J].
Grasberger, BL ;
Lu, TB ;
Schubert, C ;
Parks, DJ ;
Carver, TE ;
Koblish, HK ;
Cummings, MD ;
LaFrance, LV ;
Milkiewicz, KL ;
Calvo, RR ;
Maguire, D ;
Lattanze, J ;
Franks, CF ;
Zhao, SY ;
Ramachandren, K ;
Bylebyl, GR ;
Zhang, M ;
Manthey, CL ;
Petrella, EC ;
Pantoliano, MW ;
Deckman, IC ;
Spurlino, JC ;
Maroney, AC ;
Tomczuk, BE ;
Molloy, CJ ;
Bone, RF .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) :909-912
[8]   Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold [J].
Hardcastle, Ian R. ;
Ahmed, Shafiq U. ;
Atkins, Helen ;
Farnie, Gillian ;
Golding, Bernard T. ;
Griffin, Roger J. ;
Guyenne, Sabrina ;
Hutton, Claire ;
Kallblad, Per ;
Kemp, Stuart J. ;
Kitching, Martin S. ;
Newell, David R. ;
Norbedo, Stefano ;
Northen, Julian S. ;
Reid, Rebecca J. ;
Saravanan, K. ;
Willems, Henriette M. G. ;
Lunec, John .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) :6209-6221
[9]   Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain [J].
Kussie, PH ;
Gorina, S ;
Marechal, V ;
Elenbaas, B ;
Moreau, J ;
Levine, AJ ;
Pavletich, NP .
SCIENCE, 1996, 274 (5289) :948-953
[10]   p53, the cellular gatekeeper for growth and division [J].
Levine, AJ .
CELL, 1997, 88 (03) :323-331